SNAI2 and neoplasm: We showed that loss of FILIP1L expression increases with tumor progression, resulting in a significant difference between primary and metastatic ovarian cancer samples, whereas the levels of β-catenin and SLUG increase with tumor progression (Figure 1A, 1B and Supplementary Figure S1A).